Skip to main content
Deborah Forst, MD, Neurology, Boston, MA

DeborahAnneForstMD

Neurology Boston, MA

Neurooncology

Clinical Fellow in Neuro-Oncology, Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women's Hospital

Dr. Forst is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Forst's full profile

Already have an account?

  • Office

    55 Fruit St
    # 9E
    Boston, MA 02114
    Phone+1 617-724-8770
    Fax+1 617-724-8669

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Neuro-Oncology, 2014 - 2017
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2011 - 2014
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 2010 - 2011
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2026
  • ME State Medical License
    ME State Medical License 2023 - 2026
  • NH State Medical License
    NH State Medical License 2023 - 2025
  • VT State Medical License
    VT State Medical License 2023 - 2024
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Rapid Test of Cerebrospinal Fluid Decreases Time to Diagnosis for Brain Tumors
    Rapid Test of Cerebrospinal Fluid Decreases Time to Diagnosis for Brain TumorsJune 18th, 2024
  • Rapid Test of Cerebrospinal Fluid Found to Decrease Time to Diagnosis for Brain Tumors
    Rapid Test of Cerebrospinal Fluid Found to Decrease Time to Diagnosis for Brain TumorsJune 19th, 2024

Professional Memberships